Crossmark

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’

Crossref DOI link: https://doi.org/10.1136/openhrt-2022-001999

Published Online: 2022-08-12

Published Print: 2022-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Pufulete, Maria https://orcid.org/0000-0002-1775-1949
Harris, Jessica

Pouwels, Koen

Reeves, Barney C

Lasserson, Daniel

Loke, Yoon K

Mumford, Andrew

Mahadevan, Kalaivani https://orcid.org/0000-0002-9414-6945
Johnson, Thomas W
Clinical Trials ^BETA

Clinical trials referenced in this document:

isrctn76607611 at ISRCTN.org

Documents that mention this clinical trial

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
https://doi.org/10.1136/openhrt-2022-001999
Funding

Funding for this research was provided by:

Health Technology Assessment Programme (HTA 14/192/89)
License Information

License valid from 2022-08-12

Document is current

Any future updates will be listed below